- Nachrichtendetail
-
24.04.2024 03:34:32 - dpa-AFX: *HANMI, MERCK TO EVALUATE 'BH3120'- KEYTRUDA IN PHASE 1 TRIAL IN PROGRESSIVE OR METASTATIC SOLID TUMOR
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
MERCK CO. DL-,01 | A0YD8Q | Xetra | 121,800 | 13.05.24 09:04:22 | +0,800 | +0,66% | 120,600 | 121,400 | 121,800 | 121,000 |
